logo
Select company
Select metric
$ -7.17MConsolidated Income
VS
Market
38
Sector
71
Industry
85
History
78
$ 3.03Close
$ 1.6 - $ 3.99 52-Week Range
Ticker Information

Ticker

NRXS

Company Name

NEURAXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NEURAXIS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRXS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -7.17M
3/31/2025$ -8.4M
12/31/2024$ -8.24M
9/30/2024$ -12.11M
6/30/2024$ -15.26M
3/31/2024$ -14.57M
12/31/2023$ -14.63M
9/30/2023$ -9.33M
12/31/2022$ -4.78M
12/31/2021$ -3.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEURAXIS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -3.03M.
  • Over the past 5 years, NEURAXIS INC's average Cons. Inc. has been $ -9.75M.
  • The median Cons. Inc. for NEURAXIS INC during this period was $ -8.86M
  • NEURAXIS INC reached its highest Cons. Inc. over the past 5 years at $ -3.03M.
  • The lowest Cons. Inc. recorded by NEURAXIS INC in the same timeframe $ -15.26M

NEURAXIS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CAMP : CAMP4 THERAPEUTICS CORP $ -51.78MDYAI : DYADIC INTERNATIONAL INC $ -5.58MLPCN : LIPOCINE INC $ -4.51MTRAW : TRAWS PHARMA INC $ -17.82MLSTA : LISATA THERAPEUTICS INC $ -18.92MSTTK : SHATTUCK LABS INC $ -61.51MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MLGVN : LONGEVERON INC $ -18.54MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MCLSD : CLEARSIDE BIOMEDICAL INC $ -27.71M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

NRXS - Consolidated Income, Last 5 years

$ -15.26M

Minimum

Jun 30, 2024

$ -3.03M

Maximum

Dec 31, 2021

$ -9.75M

Average

$ -8.86M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M